BNP/CALL/MERCK & CO./85/0.1/20.06.25 | Market Closed - Deutsche Boerse AG 15:50:32 2024-07-05 EDT | ||
| 4.09 EUR | +2.25% |
|
| Current month | -1.68% | ||
| 1 month | -6.19% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-07-05 | 4.09 | +2.25% |
| 24-07-04 | 4 | -1.23% |
| 24-07-03 | 4.05 | -4.93% |
| 24-07-02 | 4.26 | -1.16% |
| 24-07-01 | 4.31 | +3.61% |
Delayed Quote Deutsche Boerse AG
Last update July 05, 2024 at 03:50 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | 
BNP Paribas
|
| WKN | PZ1ESR |
| ISIN | DE000PZ1ESR7 |
| Date issued | 2023-11-15 |
| Strike | 85 $ |
| Maturity | 2025-06-20 (348 Days) |
| Parity | 10 : 1 |
| Emission price | 2.1 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.88 € |
|---|---|
| Lowest since issue | 1.97 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
126.4
USD
Average target price
142.7
USD
Spread / Average Target
+12.84%
- Stock Market
- Warrants
- Warrant
